Developing an Arene Binuclear Ruthenium(II) Complex to Induce Ferroptosis and Activate the cGAS-STING Pathway: Targeted Inhibiting Growth and Metastasis of Triple Negative Breast Cancer
Journal of Medicinal Chemistry · 14.11.2024 · 67 (21) · 19573-19585
DOI: 10.1021/acs.jmedchem.4c01908 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 22.10.2024. Verfasst von Gang Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medici…. Hauptthemen laut MEDLINE: Ferroptosis, Triple Negative Breast Neoplasms, Membrane Proteins, Ruthenium. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: Natural Science Foundation of Guangxi Zhuang Autonomous Region, Guangxi Normal University, National Natural Science Foundation of China.
Abstract (Originalsprache)
To effectively inhibit the growth and metastasis of triple-negative breast cancer (TNBC), we developed a high-efficiency and low-toxicity arene ruthenium (Ru) complex based on apoferritin (AFt). To achieve this, we optimized a series of Ru(II) 1,10-phenanthroline-2,9-diformaldehyde thiosemicarbazone complexes by studying their structure-activity relationships to obtain an arene binuclear Ru(II) complex (C5) with significant cytotoxicity and high accumulation in the mitochondria of tumor cells. Subsequently, a C5-AFt nanoparticle (NPs) delivery system was constructed. We found that the C5/C5-AFt NPs effectively inhibited TNBC growth and metastasis with few side effects. The C5-AFt NPs improved the anticancer and targeting abilities of C5 in vivo. Moreover, we confirmed the mechanism by which C5/C5-AFt NPs inhibit tumor growth and metastasis via mitochondrial damage-mediated ferroptosis and activation of the cGAS-STING pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Collaborative Innovati…
- School of Pharmaceutical Sciences, Jiangxi Normal University, Nanchang, Jiangxi 330022, China.
Förderung
- Natural Science Foundation of Guangxi Zhuang Autonomous Region
- Guangxi Normal University
- National Natural Science Foundation of China
Zitieren
APA
Xu, G., Liang, Q., Gao, L., Xu, S., Luo, W., Wu, Q., Li, J., Zhang, Z., Liang, H., & Yang, F. (2024). Developing an Arene Binuclear Ruthenium(II) Complex to Induce Ferroptosis and Activate the cGAS-STING Pathway: Targeted Inhibiting Growth and Metastasis of Triple Negative Breast Cancer. Journal of Medicinal Chemistry, 67(21), 19573-19585. https://doi.org/10.1021/acs.jmedchem.4c01908
Vancouver
Xu G, Liang Q, Gao L, Xu S, Luo W, Wu Q, et al. Developing an Arene Binuclear Ruthenium(II) Complex to Induce Ferroptosis and Activate the cGAS-STING Pathway: Targeted Inhibiting Growth and Metastasis of Triple Negative Breast Cancer. Journal of Medicinal Chemistry. 2024;67(21):19573-19585. doi:10.1021/acs.jmedchem.4c01908
BibTeX
@article{Xu2024,
author = {Xu, Gang and Liang, Qiongyue and Gao, Lijuan and Xu, Shihang and Luo, Weicong and Wu, Qiuming and Li, Jingyuan and Zhang, Zhenlei and Liang, Hong and Yang, Feng},
title = {Developing an Arene Binuclear Ruthenium(II) Complex to Induce Ferroptosis and Activate the cGAS-STING Pathway: Targeted Inhibiting Growth and Metastasis of Triple Negative Breast Cancer},
journal = {Journal of Medicinal Chemistry},
year = {2024},
volume = {67},
number = {21},
pages = {19573--19585},
doi = {10.1021/acs.jmedchem.4c01908}
}
EUVIMED